Yu Min

Sichuan University

H指数:15

被引数:787

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

CXCL10/SLC11A1 Axis Exacerbates Septic Liver Injury by Regulating Neutrophil Extracellular Traps Formation to Drive Macrophage Pro‑Inflammatory Polarization

CXCL10/SLC11A1轴通过调控中性粒细胞胞外陷阱形成来驱动巨噬细胞促炎极化，从而加剧脓毒症性肝损伤

Advanced Science

IF14.1

2026-07-280

OAAI

ZBP1 Drives CD8+ T cell-mediated anti-tumor immunity in head and neck squamous cell carcinoma

ZBP1 驱动头颈部鳞状细胞癌中 CD8+ T 细胞介导的抗肿瘤免疫

PLoS Genetics

IF3.7

2026-05-270

Radio-Activable Gold-Single-Atom-Based Artificial Enzymes with Cascade Biocatalysis and Enhanced Radiosensitization to Prevent Metastasis and Recurrence in Malignancies

放射性激活的金-单原子基人工酶，具有级联生物催化和增强放射增敏作用，以防止恶性肿瘤的转移和复发

Journal of the American Chemical Society

IF15.6

2026-02-110

PRE

LBX2 promotes colorectal cancer progression via the glycosylation and lactylation positive feedback

LBX2通过糖基化和乳酰化的正反馈促进结直肠癌进展。

Cell Death Discovery

IF7

2025-12-120

OAAI

Acute sinusitis complicated by purulent cavernous sinus thrombosis: A case report

急性鼻窦炎并发化脓性海绵窦血栓：一个病例报告

Asian Journal of Surgery

IF3.8

2025-11-130

OAAI

Metallosalphen-Covalent Organic Framework-Based Semiconducting Artificial Enzymes with Radio-Activable Antitumor Immunity for Suppressing Tumor Metastasis and Recurrence

金属losalphen-共价有机骨架基半导体人工酶，具有放射激活的抗肿瘤免疫能力，用于抑制肿瘤转移和复发

ACS Nano

IF16

2025-10-170

PRE

Validation of an albumin-indocyanine green-based China liver cancer staging system to evaluating resectable hepatocellular carcinoma patients and comparison with the Child-Pugh-based China liver cancer staging system

FRONTIERS IN ONCOLOGY

IF3.3

2025-02-200

OAAI

Associations and potential epigenetic changes between air pollution and osteoarthritis risk and survival: Insights from a prospective cohort study

ECOTOXICOLOGY AND ENVIRONMENTAL SAFETY

IF6.1

2025-01-010

OAAI

Comprehensive analysis of the value of angiogenesis and stemness-related genes in the prognosis and immunotherapy of ovarian cancer

BIOFACTORS

IF5

2024-12-201

Comment on The systemic inflammation response index as a risk factor for hepatic fi brosis and long-term mortality among individuals with metabolic dysfunction-associated steatotic liver disease

NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES

IF3.7

2024-12-010

PRE

Letter regarding 'Impact of MASLD and MetALD on clinical outcomes: A meta-analysis of preliminary evidence'

LIVER INTERNATIONAL

IF5.2

2024-09-241

PRE

Joint association of physical activity and dietary quality with survival among US cancer survivors: a population-based cohort study

INTERNATIONAL JOURNAL OF SURGERY

IF10.1

2024-09-012

OAAI

Prophylactic central neck dissection for cN0 papillary thyroid carcinoma: is there any difference between western countries and China? A systematic review and meta-analysis

FRONTIERS IN ENDOCRINOLOGY

IF4.6

2023-07-279

OAAI

A multi-dimensional nomogram to predict non-sentinel lymph node metastases in T1-2HR+breast cancer

FRONTIERS IN ENDOCRINOLOGY

IF4.6

2023-07-052

OAAI

Is Age > 55 years an optimal cutoff point among patients with differentiated thyroid Microcarcinoma? a preliminary study

ORAL ONCOLOGY

IF3.9

2022-07-010

PRE

Hashimoto's Thyroiditis Is Associated With Central Lymph Node Metastasis in Classical Papillary Thyroid Cancer: Analysis from a High-Volume Single-Center Experience

桥本甲状腺炎与经典乳头状甲状腺癌的中央淋巴结转移相关: 来自高容量单中心经验的分析

FRONTIERS IN ENDOCRINOLOGY

IF4.6

2022-05-209

OAAI

Prognostic Factors and Models for Elderly (≥70 Years Old) Primary Operable Triple-Negative Breast Cancer: Analysis From the National Cancer Database

FRONTIERS IN ENDOCRINOLOGY

IF4.6

2022-03-179

OAAI

Identifying and Validating of an Autophagy-Related Gene Signature for the Prediction of Early Relapse in Breast Cancer

FRONTIERS IN ENDOCRINOLOGY

IF4.6

2022-02-165

OAAI

Research Progress of Bile Acids in Cancer

胆汁酸在肿瘤中的研究进展

FRONTIERS IN ONCOLOGY

IF3.3

2022-01-2033

OAAI

Cancer-Specific Survival Outcome in Early-Stage Young Breast Cancer: Evidence From the SEER Database Analysis

FRONTIERS IN ENDOCRINOLOGY

IF4.6

2022-01-1811

OAAI

Yu Min

个人简介

教育背景

工作经历

荣誉奖项

研究方向